Cu<sup>2+</sup>/Zn<sup>2+</sup> “Antimicrobial Chamber” with Self-Enhanced Photothermal Activity Supports Infected Wound Healing
Wound healing of drug-resistant bacterial infection is a major challenge in clinical practice, and existing treatments suffer from the drawbacks of high dosage, low efficiency, and insufficient biosafety. Herein, we coated ultrasmall copper sulfide nanoparticles (CuS NPs) into zeolitic imidazolate framework-8 (ZIF-8) and modified them with polydopamine (PDA) to obtain CuS@ZIF-8@PDA NPs for bacterial infection wound treatment. Due to the presence of CuS and the degradability of ZIF-8, CuS@ZIF-8@PDA NPs can continuously release Cu<sup>2+</sup> and Zn<sup>2+</sup> in a slightly acidic environment under near-infrared (NIR) irradiation. Furthermore, the introduction of PDA endows it with an excellent photothermal property. The synergistic effect of dual ions/photothermal enables it to effectively eradicate <i>Staphylococcus aureus</i> (<i>S. aureus</i>) and <i>Escherichia coli</i> (<i>E. coli</i>). Moreover, <i>in vivo</i> experimental results confirm that released Cu<sup>2+</sup> and Zn<sup>2+</sup> can promote epithelial regeneration, thereby accelerating wound healing. In the bacterially infected mouse model, CuS@ZIF-8@PDA NPs exhibit excellent synergistic antimicrobial and wound healing effects, while having no toxic side effects on major organs. The study of the dual-ion/photothermal synergistic antibacterial strategy based on CuS@ZIF-8@PDA NPs provides a new insight into bacterial infection wound repair.
Authors
- Hanzhu Shi
- Xiuhong Zhou
- Lu Li (ORCID: https://orcid.org/0000-0001-8681-2795)
- Jue Wang (ORCID: https://orcid.org/0000-0002-3641-3136)
- Xue Song Zhou (ORCID: https://orcid.org/0000-0002-4022-9673)
- Chenwei Dai (ORCID: https://orcid.org/0000-0003-4605-4357)
- Xuechao Dong
Institutions
- Northeast Normal University (CN)
- Jilin University (CN)
- Anhui Medical University (CN)
- First Hospital of Jilin University (CN)
- Anhui Academy of Medical Sciences (CN)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.5c00089
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.35